FH
Fred Hassan
Director

Fred Hassan insider trades: Precigen (PGEN) stock purchases

Director, Precigen Last trade Aug 14, 2023 93 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2008
12
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Fred reports to the SEC

and 6 more companies

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 14, 2023PGEN↑ Buy$998K
Dec 29, 2021BBIO↑ Buy$273K
Dec 1, 2016XON↑ Buy$200K
Aug 19, 2015AMGN↑ Buy$502K
Aug 29, 2013VRX↑ Buy$5.0M
Mar 3, 2010TWX↑ Buy$1.0M
Apr 24, 2008SGP↑ Buy$2.0M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other PGEN insiders

Open-market trades in the last 12 months

About Fred Hassan's insider trades

Fred Hassan is a director at Precigen (PGEN). Since Apr 24, 2008, Fred has reported 7 open-market purchases worth $10.0M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (63 filings), option exercises (21 filings), shares returned to the company (3 filings), shares withheld for taxes (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PGEN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.